Kolon Life Science (XKRX:102940) Other Operating Expense : ₩9,167 Mil (TTM As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Kolon Life Science Other Operating Expense?

Kolon Life Science's Other Operating Expense for the three months ended in Mar. 2024 was ₩1,866 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩9,167 Mil.

Kolon Life Science's quarterly Other Operating Expense increased from Sep. 2023 (₩2,269 Mil) to Dec. 2023 (₩2,946 Mil) but then declined from Dec. 2023 (₩2,946 Mil) to Mar. 2024 (₩1,866 Mil).

Kolon Life Science's annual Other Operating Expense declined from Dec. 2021 (₩4,049 Mil) to Dec. 2022 (₩1,562 Mil) but then increased from Dec. 2022 (₩1,562 Mil) to Dec. 2023 (₩10,191 Mil).

Kolon Life Science Other Operating Expense Historical Data

The historical data trend for Kolon Life Science's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon Life Science Other Operating Expense Chart

Kolon Life Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

49,841.67

27,546.47

4,048.90

1,562.08

10,190.61

Kolon Life Science Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															2,889.84	2,085.93	2,269.30	2,945.53	1,865.75

Kolon Life Science Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩9,167 Mil.

Kolon Life Science Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Kolon Life Science's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kolon Life Science (XKRX:102940) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kolon Life Science Inc (XKRX:102940) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

110, Magokdong-ro, Gangseo-gu, One & Only Tower, Seoul, KOR

Website

http://www.kolonls.co.kr

Kolon Life Science Inc develops, manufactures and sells Biopharmaceuticals, Active pharmaceutical ingredients, Antimicrobials and Water solutions. Its products include Invossa, KLS-1010, KLS-2020, Azilsartan, Besfloc etc. The company has manufacturing facilities in Chungju, Eumsung and Kimchun.

Kolon Life Science (XKRX:102940) Headlines

No Headlines